Filter posts

ICYMI: WSJ Editors on “Biotech’s Breakthrough Year”

2017 was an amazing year for biomedical advances, with 46 novel drug approvals, a near …

Celebrating 21st Century Cures One Year Later

Today marks an important day for America. It was just one year ago that the …

#BIF17: Looking Ahead to 2018 Policy Landscape

The past year has seen a number of important changes in the legislative and policy …

ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

Rewarding for quality – not quantity – is becoming more and more common in health …

ICYMI: Op-Ed by Rep. Gus Bilirakis on Lowering Drug Costs

Yesterday, U.S. Representative Gus Bilirakis of Florida published an op-ed outlining how to “Lower Drug …

Failing Fast: Innovation in the Search for a Cure to Alzheimer’s

For those of us who have watched family members suffer the decline that results from …

Alzheimer’s Research: Where We’ve Failed and What’s To Come

Alzheimer’s disease is a rapidly growing public health crisis. Today an estimated 5.4 million Americans …

BIO Letter of Support for 21st Century Cures Legislation

Today, BIO sent a letter to Reps. Boehner and Pelosi in support of the 21st …

Time: How to Breathe New Life Into America's Health-Care System

Last week, Rep. Fred Upton (R-MI) published an op-ed – How to Breathe New Life Into America’s …

BIO Applauds Energy and Commerce Health Subcommittee for Approving 21st Century Cures Act

Today, the Biotechnology Industry Organization (BIO) praises the Energy and Commerce Health Subcommittee for approving …